Barclays PLC Cooper Companies, Inc. Call Options Transaction History

Barclays PLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2019 Feb 10, 2020	SELL	$281.18 - $322.05 $731,068 - $837,330	-2,600 Reduced 38.24%	4,200 $1.35 Million
Q3 2019 Nov 14, 2019	BUY	$294.25 - $341.49 $1.82 Million - $2.12 Million	6,200 Added 1033.33%	6,800 $2.02 Million
Q2 2019 Aug 14, 2019	SELL	$279.29 - $336.89 $195,503 - $235,823	-700 Reduced 53.85%	600 $202,000
Q4 2018 Feb 14, 2019	SELL	$232.7 - $281.66 $209,430 - $253,494	-900 Reduced 40.91%	1,300 $331,000
Q3 2018 Nov 14, 2018	BUY	$236.3 - $277.15 $141,780 - $166,290	600 Added 37.5%	2,200 $610,000
Q2 2018 Aug 14, 2018	SELL	$217.98 - $237.23 $1.44 Million - $1.57 Million	-6,600 Reduced 80.49%	1,600 $377,000
Q1 2018 May 15, 2018	BUY	$218.74 - $251.43 $1.03 Million - $1.18 Million	4,700 Added 134.29%	8,200 $1.88 Million
Q4 2017 Feb 14, 2018	BUY	$217.88 - $244.43 $762,580 - $855,505	3,500	3,500 $763,000

1.59M

Ticker COO
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 49,346,000
Market Cap $4.92B
Description
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.